PTC Therapeutics rises as UBS restarts coverage with buy rating08/27/2024 narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency has…
